全文获取类型
收费全文 | 1097篇 |
免费 | 76篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 20篇 |
妇产科学 | 114篇 |
基础医学 | 173篇 |
口腔科学 | 19篇 |
临床医学 | 85篇 |
内科学 | 201篇 |
皮肤病学 | 36篇 |
神经病学 | 77篇 |
特种医学 | 26篇 |
外科学 | 159篇 |
综合类 | 9篇 |
预防医学 | 82篇 |
眼科学 | 5篇 |
药学 | 47篇 |
中国医学 | 6篇 |
肿瘤学 | 121篇 |
出版年
2023年 | 8篇 |
2022年 | 13篇 |
2021年 | 28篇 |
2020年 | 9篇 |
2019年 | 17篇 |
2018年 | 20篇 |
2017年 | 23篇 |
2016年 | 22篇 |
2015年 | 39篇 |
2014年 | 38篇 |
2013年 | 40篇 |
2012年 | 76篇 |
2011年 | 83篇 |
2010年 | 37篇 |
2009年 | 39篇 |
2008年 | 75篇 |
2007年 | 58篇 |
2006年 | 57篇 |
2005年 | 67篇 |
2004年 | 48篇 |
2003年 | 39篇 |
2002年 | 52篇 |
2001年 | 24篇 |
2000年 | 20篇 |
1999年 | 26篇 |
1998年 | 16篇 |
1997年 | 11篇 |
1996年 | 14篇 |
1995年 | 6篇 |
1994年 | 11篇 |
1993年 | 9篇 |
1992年 | 9篇 |
1990年 | 11篇 |
1989年 | 6篇 |
1988年 | 12篇 |
1987年 | 7篇 |
1986年 | 11篇 |
1985年 | 10篇 |
1984年 | 7篇 |
1983年 | 5篇 |
1982年 | 10篇 |
1981年 | 7篇 |
1980年 | 6篇 |
1979年 | 6篇 |
1976年 | 6篇 |
1973年 | 5篇 |
1971年 | 4篇 |
1969年 | 4篇 |
1968年 | 5篇 |
1966年 | 4篇 |
排序方式: 共有1181条查询结果,搜索用时 22 毫秒
41.
Brendan R. Jackson Monique Salter Cheryl Tarr Amanda Conrad Emily Harvey Lisa Steinbock Amy Saupe Alida Sorenson Lee Katz Steven Stroika Kelly A. Jackson Heather Carleton Zuzana Kucerova David Melka Errol Strain Mickey Parish Rajal K. Mody 《MMWR. Morbidity and mortality weekly report》2015,64(10):282-283
42.
43.
Lipid abnormalities and renal disease: is dyslipidemia a predictor of progression of renal disease? 总被引:2,自引:0,他引:2
Crook ED Thallapureddy A Migdal S Flack JM Greene EL Salahudeen A Tucker JK Taylor HA 《The American journal of the medical sciences》2003,325(6):340-348
Dyslipidemia is a cardiovascular disease (CVD) risk factor that is associated with enhanced atherosclerosis and plaque instability. Renal insufficiency is associated with abnormalities in lipoprotein metabolism in both the early and the advanced stages of chronic renal failure. These include alterations in apolipoprotein A (apo A)- and B- containing lipoproteins, high-density lipoproteins, and triglycerides. In animal models, these alterations in lipid metabolism and action lead to macrophage activation and infiltration in the kidney with resultant tubulointerstitial and endothelial cell injury. Limited data in humans suggest that, in addition to contributing to CVD, dyslipidemia may be a risk factor for the progression of renal disease. The effects of dyslipidemia on the kidney are mainly observed in those with other risk factors for renal disease progression such as hypertension, diabetes, and proteinuria. Renal disease is a strong risk factor for CVD and African Americans have high rates of renal disease. Therefore, examining the effects of dyslipidemia on the development or progression or renal disease will be an important question for the Jackson Heart Study and is the topic of this review. 相似文献
44.
Ransalu Senanayake Errol R. Hoffmann Ravindra S. Goonetilleke 《Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale》2013,231(3):367-379
Current models for targeted-tracking are discussed and shown to be inadequate as a means of understanding the combined task of tracking, as in the Drury’s paradigm, and having a final target to be aimed at, as in the Fitts’ paradigm. It is shown that the task has to be split into components that are, in general, performed sequentially and have a movement time component dependent on the difficulty of the individual component of the task. In some cases, the task time may be controlled by the Fitts’ task difficulty, and in others, it may be dominated by the Drury’s task difficulty. Based on an experiment carried out that captured movement time in combinations of visually controlled and ballistic movements, a model for movement time in targeted-tracking was developed. 相似文献
45.
46.
47.
Kurowska EM Dresser G Deutsch L Bassoo E Freeman DJ 《Annals of nutrition & metabolism》2003,47(1):16-21
Coenzyme Q10 (CoQ10) is synthesized by the human body and found in certain foods. Daily supplementation of CoQ10 could protect against heart disease but the bioavailability of CoQ10 supplements depends on the formulation taken. We compared the bioavailability and antioxidant properties of two commercial CoQ10 formulations, a commercial grade CoQ10 powder (commercial grade CoQ) and a new BT-CoQ10 BIO-TRANSFORMED (BT-CoQ10) obtained by fermentation of a soy-based, CoQ10-rich media with baker's yeast. Eleven healthy individuals participated in a randomized two-way crossover trial, with a 3-week washout period. Capsules containing 300 mg of either BT-CoQ10 or commercial grade CoQ10 were given daily for 1 week and multiple blood samples were taken for CoQ10, glutathione and glutathione peroxidase (GPx) determination. In 3 subjects, baseline plasma CoQ10 levels were lower prior to BT than prior to commercial grade CoQ treatment. In the remaining participants, ingestion of BT vs. commercial grade CoQ significantly increased maximum plasma CoQ10 concentration (+126%, p = 0.04) and tended to increase CoQ10 area under the curve from 0 to 24 h (+160%, p = 0.07). One week of treatment with each formulation increased plasma CoQ10 but did not alter plasma glutathione or GPx activity. The enhanced bioavailability of the BT product might be due to its predominantly reduced, hydrophilic membrane-complex form. 相似文献
48.
Jorgetti V López BD Caorsi H Ferreira A Palma A Menendez P Douthat W Olaizola I Ribeiro S Jarava C Moreira E Cannata J 《The American journal of the medical sciences》2000,320(2):76-80
The various forms of renal osteodystrophy are predominant hyperparathyroid bone disease, mixed uremic osteodystrophy, low turnover osteomalacia, and adynamic bone disease. The present study analyses a total number of 1,209 bone biopsies from 5 different countries (Brazil, Uruguay, Argentina, Portugal, and Spain). Low turnover osteomalacia and mixed uremic osteodystrophy were more common in Brazil, Uruguay, and Argentina than in Portugal and Spain whereas predominant hyperparathyroid bone disease was seen more often in Portugal and Spain. In all centers, independent of the aluminum staining technique used, the extent of aluminum deposited in bone was greater in patients presenting with low bone turnover, whether from low turnover osteomalacia or adynamic bone disease, than in the predominant hyperparathyroid bone disease. In summary, even though recent reports have indicated that, over the last decade, the incidence of aluminum-induced toxicity was reduced, aluminum still seems to be implicated in a great percentage of symptomatic low bone remodelling lesions in Iberoamerica. 相似文献
49.
Ma W Halweg CJ Menendez D Resnick MA 《Proceedings of the National Academy of Sciences of the United States of America》2012,109(17):6590-6595
Poly(ADP-ribose) polymerase (PARP) inhibitors can generate synthetic lethality in cancer cells defective in homologous recombination. However, the mechanism(s) by which they affect DNA repair has not been established. Here we directly determined the effects of PARP inhibition and PARP1 depletion on the repair of ionizing radiation-induced single- and double-strand breaks (SSBs and DSBs) in human lymphoid cell lines. To do this, we developed an in vivo repair assay based on large endogenous Epstein-Barr virus (EBV) circular episomes. The EBV break assay provides the opportunity to assess quantitatively and simultaneously the induction and repair of SSBs and DSBs in human cells. Repair was efficient in G1 and G2 cells and was not dependent on functional p53. shRNA-mediated knockdown of PARP1 demonstrated that the PARP1 protein was not essential for SSB repair. Among 10 widely used PARP inhibitors, none affected DSB repair, although an inhibitor of DNA-dependent protein kinase was highly effective at reducing DSB repair. Only Olaparib and Iniparib, which are in clinical cancer therapy trials, as well as 4-AN inhibited SSB repair. However, a decrease in PARP1 expression reversed the ability of Iniparib to reduce SSB repair. Because Iniparib disrupts PARP1-DNA binding, the mechanism of inhibition does not appear to involve trapping PARP at SSBs. 相似文献
50.
B Corominas-Faja R Quirantes-Piné C Oliveras-Ferraros A Vazquez-Martin S Cufí B Martin-Castillo V Micol J Joven A Segura-Carretero JA Menendez 《Aging》2012,4(7):480-498
Metabolomic fingerprint of breast cancer cells treated with the antidiabetic drug metformin revealed a significant accumulation of 5-formimino-tetrahydrofolate, one of the tetrahydrofolate forms carrying activated one-carbon units that are essential for the de novo synthesis of purines and pyrimidines. De novo synthesis of glutathione, a folate-dependent pathway interconnected with one-carbon metabolism was concomitantly depleted in response to metformin. End-product reversal studies demonstrated that thymidine alone leads to a significant but incomplete protection from metformin's cytostatic effects. The addition of the substrate hypoxanthine for the purine salvage pathway produces major rightward shifts in metformin's growth inhibition curves. Metformin treatment failed to activate the DNA repair protein ATM kinase and the metabolic tumor suppressor AMPK when thymidine and hypoxanthine were present in the extracellular milieu. Our current findings suggest for the first time that metformin can function as an antifolate chemotherapeutic agent that induces the ATM/AMPK tumor suppressor axis secondarily following the alteration of the carbon flow through the folate-related one-carbon metabolic pathways. 相似文献